Core Points - Newmont Corporation is facing a class action lawsuit due to disappointing financial results and operational challenges reported in Q3 2024 [3][4] - The stock price of Newmont dropped significantly from $57.74 to $49.25 following the announcement of lower production and higher operating costs [3] Summary by Sections Class Action Details - Shareholders who purchased Newmont shares between February 22, 2024, and October 23, 2024, are encouraged to contact the Gross Law Firm for potential lead plaintiff appointment [3][4] - The deadline for shareholders to register for the class action is April 1, 2025 [4] Financial Performance - Newmont's Q3 2024 report highlighted disappointing EBITDA, decreased production, and increased operating costs, particularly at its two Tier 1 assets [3] - The announcement led to a significant decline in stock price, indicating investor reaction to the negative news [3] Legal Representation - The Gross Law Firm aims to protect investors' rights and seeks recovery for losses incurred due to misleading statements or omissions by companies [5] - Participation in the class action does not require appointment as lead plaintiff and involves no cost to shareholders [4][5]

Core Viewpoint - Grocery Outlet Holding Corp. is facing a class action lawsuit due to significant financial underperformance and lowered guidance, which has led to a notable decline in its stock price [3][4]. Summary by Relevant Sections Class Period and Allegations - The class period for the lawsuit is from November 7, 2023, to May 7, 2024 [3]. - On May 7, 2024, Grocery Outlet announced first-quarter financial results that were significantly below expectations and reduced its guidance for the second quarter and the full fiscal year 2024 [3]. - The company cited "unforeseen systems transition costs" and "residual expense from our commission support program" as reasons for the disappointing results [3]. - Following this announcement, the stock price dropped to $20.88 per share on May 8, 2024, marking a decline of approximately 19.38% in one day [3]. Next Steps for Shareholders - Shareholders who purchased shares during the specified class period are encouraged to register for the class action by March 31, 2025 [4]. - Registration allows shareholders to be enrolled in a portfolio monitoring system for updates on the case [4]. - There is no cost or obligation for shareholders to participate in the case [4]. Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

Core Viewpoint - Zynex, Inc. is facing a class action lawsuit due to allegations of issuing misleading statements and inflating revenue through improper business practices during the class period from March 13, 2023, to March 11, 2025 [3][4]. Summary by Relevant Sections Allegations - The complaint alleges that Zynex shipped products, including electrodes, in excess of need, leading to inflated revenue [3] - The company's practice of filing false claims has drawn scrutiny from insurers, including the U.S. military health insurance program, Tricare [3] - As a result of these practices, Zynex is likely to face adverse consequences, including removal from insurer networks and penalties from the federal government [3] - The positive statements made by the defendants regarding the company's business and prospects were materially misleading and lacked a reasonable basis [3] Class Action Details - Shareholders who purchased shares of ZYXI during the specified class period are encouraged to register for the class action [4] - The deadline to seek lead plaintiff status is May 19, 2025, and there is no cost or obligation to participate [4] Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors affected by deceit and illegal business practices [5] - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5]

Core Viewpoint - The Trade Desk, Inc. is facing allegations of issuing materially false and misleading statements regarding its AI forecasting tool, Kokai, which has led to execution challenges and negatively impacted revenue growth [1][2]. Group 1: Allegations and Impact - The complaint alleges that during the class period from May 9, 2024, to February 12, 2025, The Trade Desk experienced significant execution challenges in rolling out its AI tool, Kokai, transitioning clients from the older platform, Solimar [1]. - These execution challenges delayed the Kokai rollout, which in turn negatively impacted the company's business operations and revenue growth [1]. - As a result of these issues, the positive statements made by the company regarding its business and prospects were deemed materially false and misleading [1]. Group 2: Shareholder Actions - Shareholders who purchased shares of TTD during the specified class period are encouraged to contact the Gross Law Firm for possible lead plaintiff appointment, although this is not required to partake in any recovery [1][2]. - The deadline for shareholders to register for the class action is April 21, 2025, and they will be enrolled in a portfolio monitoring software for status updates throughout the case [2]. Group 3: Law Firm's Mission - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered due to deceit, fraud, and illegal business practices [3]. - The firm aims to ensure that companies adhere to responsible business practices and seeks recovery for investors who incurred losses from misleading statements or omissions that led to artificial inflation of stock prices [3].

NEW YORK, March 24, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Neumora Therapeutics, Inc. (NASDAQ: NMRA).Shareholders who purchased shares of NMRA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/neumora-therapeutics-inc-loss-submission-form/?id=137688&from=4CLASS PERIOD: ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Crocs, Inc. regarding a class action lawsuit alleging misleading statements and failure to disclose critical information about the company's revenue growth and inventory management during a specified period [1][2]. Summary by Sections Allegations - The lawsuit claims that during the class period from November 3, 2022, to October 28, 2024, Crocs, Inc. made materially false and misleading statements regarding the sustainability of HEYDUDE's revenue growth, which was largely driven by stocking third-party wholesalers and retailers after its acquisition in February 2022 [1]. - It is alleged that as retail partners began to destock excess inventory, the demand for products decreased, negatively impacting Crocs' financial results [1]. - The representations made by the defendants about the company's business operations and prospects were claimed to be materially false and misleading, lacking a reasonable basis [1]. Next Steps for Shareholders - Shareholders who purchased shares of CROX during the specified timeframe are encouraged to register for the class action, with a deadline set for March 24, 2025 [2]. - Upon registration, shareholders will be enrolled in a portfolio monitoring system to receive updates throughout the case lifecycle [2]. Firm's Commitment - The Gross Law Firm is recognized nationally for its commitment to protecting investors' rights against deceit and illegal business practices [3]. - The firm aims to ensure that companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions that inflated stock prices [3].

NEW YORK, March 20, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI).Shareholders who purchased shares of MRVI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/maravai-lifesciences-holdings-inc-loss-submission-form/?id=137092&fr ...

Group 1 - The Gross Law Firm has issued a notice to shareholders of Merck & Co., Inc. regarding a class action lawsuit related to misleading statements about Gardasil's expected revenue [1] - The class period for the lawsuit is from February 3, 2022, to February 3, 2025, during which Merck projected $11 billion in sales from Gardasil by 2030 [1] - On February 4, 2025, Merck announced it would not achieve the projected sales due to ceasing shipments to China, leading to a stock price decline of over 9% in one day [1] Group 2 - Shareholders are encouraged to register for the class action by April 14, 2025, to potentially become lead plaintiffs and receive updates on the case [2] - The Gross Law Firm aims to protect investors' rights and seeks recovery for losses incurred due to misleading statements that inflated Merck's stock price [3]

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Integral Ad Science Holding Corp. regarding a class action lawsuit due to alleged misleading statements and competitive pricing pressures affecting the company's performance [1][2]. Group 1: Allegations and Class Period - The class period for the allegations is from March 2, 2023, to February 27, 2024 [2]. - The complaint claims that IAS faced increased competitive pricing pressures, leading to price cuts to address weakening demand and slowing revenue growth [2]. - It is alleged that IAS's pricing function was no longer favorable, impacting its ability to sustain pricing and drive price increases [2]. Group 2: Impact of Competition - Pricing has become a key differentiator for IAS in closing major renewals and new deals, indicating a shift in market dynamics [2]. - The risks associated with competition leading to increased pricing pressure have materialized, contradicting IAS's public statements [2]. Group 3: Next Steps for Shareholders - Shareholders are encouraged to register for the class action by March 31, 2025, to participate in potential recovery [3]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [3]. Group 4: Law Firm's Mission - The Gross Law Firm aims to protect investors' rights against deceit and illegal business practices, emphasizing the importance of responsible corporate behavior [4].

Core Viewpoint - Newmont Corporation is facing a class action lawsuit due to disappointing financial results and operational challenges, leading to a significant drop in its stock price [1][2]. Group 1: Allegations and Financial Impact - The class period for the lawsuit is from February 22, 2024, to October 23, 2024 [1]. - On October 23, 2024, Newmont announced disappointing EBITDA for Q3 2024, along with decreased production and increased operating costs [1]. - The company revealed that mining operations at its two Tier 1 assets would experience lower production than previously guided, with expectations of higher costs [1]. - Following the announcement, Newmont's stock price fell from $57.74 per share to $49.25 per share, a decline of approximately 14.5% [1]. Group 2: Next Steps for Shareholders - Shareholders are encouraged to register for the class action by April 1, 2025, to potentially become lead plaintiffs [2]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the case [2]. - Participation in the case incurs no cost or obligation for shareholders [2]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3].